Please provide your email address to receive an email when new articles are posted on . Through an evolution that has seen several prototypes enter and leave the scene, ultra-small drainage devices ...

Three years after Alcon pulled its CyPass Micro-Stent from the market due to safety concerns, the Novartis spinoff has found another glaucoma treatment device to take its place. The Hydrus Microstent ...

A tiny medical device no larger than an eyelash may significantly reduce eye pressure in glaucoma patients and allow some to stop using eye-drop medications, according to year-one clinical trial ...

CORONADO, California — In glaucoma patients, the implantation of an intracanalicular microstent (Hydrus, Ivantis) maintains low intraocular pressure for 2 years and reduces the need for medication, a ...

Irvine-based Ivantis Inc., an 11-year-old ophthalmic device maker of eyelash-sized stents used to treat glaucoma, couldn’t pick a better time to bring its first product, Hydrus Microstent, to market ...

The Hydrus Microstent is about the size of an eyelash--courtesy of Ivantis California's Ivantis has closed a $27 million Series B to fund studies of its Hydrus Microstent, an eyelash-sized device ...

CHICAGO -- For the first time in a multicenter randomized trial, minimally invasive glaucoma surgery (MIGS) with an intracanalicular (Schlemm's canal) stent significantly reduced long-term vision loss ...

Alcon, a subsidiary of Novartis that focuses on manufacturing eye-care products, withdrew its CyPass Micro-Stent from the global market after a long-term safety study. The devicemaker also advised ...

Ivantis Inc., the maker of one of the smallest medical devices in the world, is getting acquired at a big price. Alcon Inc., the world’s largest eye care device company, announced Nov. 8 it plans to ...

Other implants, namely the Hydrus Microstent (Ivantis) and the first- and second-generation iStent trabecular micro-bypass (Glaukos) target the Schlemm’s canal, while the third-generation iStent and ...

Thomas W. Samuelson, M.D., glaucoma specialist with Minnesota Eye Consultants, served as the HYDRUS I trial's medical monitor Click here for high-resolution version The Hydrus stent is one of several ...

CHICAGO – November 13, 2012 – A tiny medical device no larger than an eyelash may significantly reduce eye pressure in glaucoma patients and allow some to stop using eye-drop medications, according to ...